在小鼠中的BRCA2 R3052Q变体的表征支持其作为低风险变体的功能影响
Arun Prakash Mishra1, Suzanne Hartford1,2, Rajani Kant Chittela1,3
1Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
Cell death & disease
|November 19, 2023
概括
这种BRCA2 R3052Q变异,以前的意义不确定,作为一个低形态变异. 这意味着它部分失去功能,影响DNA修复,并增加对某些癌症疗法的敏感性.
科学领域:
- 遗传学 是一个遗传学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 在BRCA2的致病变体显著提高乳腺癌和卵巢癌的风险.
- 数以千计的不确定意义的BRCA2变体 (VUS) 缺乏明确的疾病风险数据.
- 这种BRCA2 p.Arg3052Gln变异具有相互矛盾的临床解释.
研究的目的:
- 为了研究BRCA2 p.Arg3052Gln变异的体内和体外功能影响.
- 使用小鼠模型确定BRCA2 R3052Q变异的致病性.
主要方法:
- 创建一个表达BRCA2 R3052Q变异的敲入鼠标模型.
- 评估小鼠的生存能力,生育能力和一般的表型.
- 在体外分析胎儿肝细胞和纤维细胞的增殖,DNA修复 (RAD51焦点) 和基因组稳定性.
- 对PARP抑制剂 (olaparib) 的敏感性评估.
主要成果:
- 同卵性和半卵性突变小鼠是可行的和肥沃的,没有明显的表型.
- 胎儿肝细胞在体外增殖减少,对olaparib过敏.
- 纤维细胞在辐射后呈现了减少的RAD51焦点形成,并在米托米辛C治疗后增加了基因组不稳定性.
- 一部分R3052Q BRCA2蛋白错误地定位到细胞质中.
结论:
- 这种BRCA2 R3052Q变体表现出功能减弱,被归类为低形态变体.
- 这种变异影响了DNA修复机制和细胞对DNA破坏剂的反应.
- 这些发现有助于对BRCA2 VUS和个性化癌症风险评估的临床解释.
相关概念视频
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K


